Immunohistochemistry revealed markedly higher IRF9 levels in tumor than in normal tissues (Figure 7A), a finding corroborated by paired analyses of ccRCC specimens (Figure 7B). Here, IRF9 is linked to nonpapillary renal cell carcinoma.